The Clorox Company
89.62USD
-1.9800 (-2.16%)
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 7.4B | 7.1B | 7.1B | — | 7.6B | 7.8B |
| Q1 | 1.7B | 1.4B | 1.8B | 1.4B | 1.9B | — |
| Q2 | 1.7B | 2.0B | 1.7B | 1.7B | 1.9B | — |
| Q3 | 1.9B | 1.8B | 1.7B | 1.7B | — | — |
| Q4 | 2.0B* | 1.9B* | 2.0B* | — | — | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | 1.20 | 2.25 | 6.52 | — | 5.81 | 6.29 |
| Q1 | .680 | .170 | .800 | .650 | 1.11 | — |
| Q2 | .800 | .750 | 1.54 | 1.29 | 1.37 | — |
| Q3 | -1.71 | -.410 | 1.50 | 1.54 | — | — |
| Q4 | 1.42* |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| 1.73* |
| 2.67* |
| — |
| — |
| — |